Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01677975 | The Value of Preoperative Dynamic Lymphscintigraphy and Ultrasoundscanning, Eventually With FNA, for Identification of Malignant Sentinel Node(s) in Patients With Melanoma | unknown | N/A | — | Rigshospitalet, DenmarkOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT01620749 | Of 18F MEL050 Using PET/CT in Metastatic Melanoma(MEL050) | unknown | Early Phase 1 | 12 | Cooperative Research Centre for Biomedical Imaging DevelopmentOTHER | 1 |
| Jun 15, 2012 |
| clinicaltrials |
| NCT01614301 | Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma | unknown | Phase 1 / Phase 2 | 136 | University of RegensburgOTHER | 1 | Jun 7, 2012 | clinicaltrials |
| NCT01584115 | Clinical Trial of a Therapeutic Vaccine With NY-ESO-1 in Combination With the Adjuvant Monophosphoryl Lipid A (MPLA) | unknown | Phase 1 / Phase 2 | 15 | Instituto de Investigação em ImunologiaOTHER | 1 | Apr 25, 2012 | clinicaltrials |
| NCT00287131 | Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients | unknown | Phase 2 | 70 | Sheba Medical CenterOTHER_GOV | 1 | Mar 29, 2012 | clinicaltrials |
| NCT00925314 | A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma | unknown | Phase 2 | 20 | Cosmo BioscienceINDUSTRY | 1 | Feb 13, 2012 | clinicaltrials |
| NCT00002763 | High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma | unknown | Phase 3 | 1,000 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 21 | Nov 16, 2011 | clinicaltrials |
| NCT01092585 | Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH | unknown | Phase 2 | 27 | Genta IncorporatedINDUSTRY | 1 | Nov 8, 2011 | clinicaltrials |
| NCT00409383 | Abraxane and Temodar Plus Genasense in Advanced Melanoma | unknown | Phase 1 | 28 | Genta IncorporatedINDUSTRY | 1 | Nov 7, 2011 | clinicaltrials |
| NCT01168050 | Efficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.(NILOMEL) | unknown | Phase 2 | 25 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 8, 2011 | clinicaltrials |
| NCT01281722 | Role of SLURP-1 in Melanoma and Melanoma Stem Cells | unknown | — | 150 | National Taiwan University HospitalOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT00746746 | A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma | unknown | Phase 2 | 30 | Ochsner Health SystemOTHER | 1 | Jan 13, 2011 | clinicaltrials |
| NCT00811759 | Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 1 / Phase 2 | 58 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Oct 7, 2010 | clinicaltrials |
| NCT00963261 | Quality of Life and Psychological Well-being in Patients With Malignant Melanoma | unknown | N/A | 600 | University Hospital FreiburgOTHER | 1 | Jun 25, 2010 | clinicaltrials |
| NCT00153569 | Multiepitope Peptide Vaccination in Melanoma | unknown | Phase 2 | 25 | Charite University, Berlin, GermanyOTHER | 1 | May 26, 2010 | clinicaltrials |
| NCT00610389 | Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 2 | 27 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT00991250 | SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma | unknown | Phase 2 | 140 | SentoClone ABINDUSTRY | 1 | Feb 5, 2010 | clinicaltrials |
| NCT00701987 | Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma | unknown | Phase 1 | 12 | Advanced Life Sciences, Inc.INDUSTRY | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00813449 | Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma(melanoma) | unknown | Phase 2 | 140 | Simcere Pharmaceutical Co., LtdOTHER | 1 | Dec 8, 2009 | clinicaltrials |
| NCT01002560 | The Identification of Novel Prognostic Markers in Melanoma | unknown | — | 500 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 27, 2009 | clinicaltrials |
| NCT00811200 | Treatment Of Radiation Retinopathy Trial(TORR) | unknown | Phase 2 / Phase 3 | 220 | Leiden University Medical CenterOTHER | 0 | Jul 2, 2009 | clinicaltrials |
| NCT00872391 | Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma | unknown | N/A | 155 | Medical University of ViennaOTHER | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00005052 | Vaccine Therapy in Treating Patients With Primary Stage II Melanoma | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 18 | Feb 9, 2009 | clinicaltrials |
| NCT00085397 | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 2 | 40 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00779714 | Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC(ChemoSensMM) | unknown | Phase 3 | 360 | University of WuerzburgOTHER | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00459849 | Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma | unknown | N/A | 175 | Barnes Retina InstituteOTHER | 1 | May 9, 2008 | clinicaltrials |
| NCT00656227 | A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision | unknown | Phase 2 | 239 | RenovoINDUSTRY | 1 | Apr 11, 2008 | clinicaltrials |
| NCT00116363 | Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma | unknown | Phase 2 | 25 | Introgen TherapeuticsINDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00383851 | Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma | unknown | Phase 2 | 60 | AttenuonINDUSTRY | 1 | Dec 6, 2007 | clinicaltrials |
| NCT00540930 | Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy | unknown | Phase 4 | 400 | Shields, Shields and AssociatesOTHER | 1 | Oct 8, 2007 | clinicaltrials |
| NCT00168870 | Study of Metastatic Ocular Melanoma | unknown | Phase 2 | 48 | Charite University, Berlin, GermanyOTHER | 1 | Aug 31, 2007 | clinicaltrials |
| NCT00406900 | Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma | unknown | — | 560 | Ludwig-Maximilians - University of MunichOTHER | 1 | Dec 6, 2006 | clinicaltrials |
| NCT00294476 | IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma | unknown | Phase 2 | 30 | GammaCanINDUSTRY | 1 | Oct 12, 2006 | clinicaltrials |
| NCT00108875 | Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer | unknown | Phase 1 / Phase 2 | 70 | Julius-Maximilians UniversityOTHER | 1 | Jul 28, 2006 | clinicaltrials |
| NCT00226408 | Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon | unknown | Phase 3 | 600 | Dermatologic Cooperative Oncology GroupOTHER | 1 | Jun 21, 2006 | clinicaltrials |
| NCT00226473 | Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma | unknown | Phase 4 | 200 | Dermatologic Cooperative Oncology GroupOTHER | 1 | Jun 21, 2006 | clinicaltrials |
| NCT00111046 | Pain Relief - Tramadol Versus Ibuprofen | unknown | Phase 1 / Phase 2 | 40 | Royal Liverpool University HospitalOTHER_GOV | 1 | Nov 10, 2005 | clinicaltrials |
| NCT00006200 | Thalidomide and Dacarbazine for Metastatic Melanoma | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00052130 | Vaccine Therapy for Patients With Stage III Melanoma | unknown | Phase 3 | 1,118 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
| NCT00052156 | Vaccine Therapy for Patients With Stage IV Melanoma | unknown | Phase 3 | 670 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Sep 3, 2012source: clinicaltrials